Through
5/19
Promising preclinical results from a new Penn Medicine study suggest an mRNA vaccine platform could limit the impact of avian flu pandemics.
Boris Striepen of Penn Vet organized the First Biennial Cryptosporidium Meeting, bringing together researchers and clinicians from around the world to discuss the problems and progress around the parasite and the diarrheal disease it causes.
Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.
A new collaborative study with Penn Vet researchers analyzed fecal samples to shed light on how the fatal disease impacts the gut microbiome in deer, providing a promising tool for disease surveillance.
As the country’s life expectancy has risen, the Malawi Longitudinal Study of Families and Health has shifted its current and future research to aging.
A Penn Medicine study finds that even modest increases in out-of-pocket costs for HIV prevention drugs could double the rate at which prescriptions go unfilled.
Letícia Marteleto, a social demographer new to Penn, does research at the intersection of fertility, Zika, COVID-19, climate conditions, urbanicity, and inequality.
Gov. Josh Shapiro, President Liz Magill, and others from the University community celebrated the new home of the Penn Institute for RNA Innovation.
Two new studies led by Phillip Scott of the School of Veterinary Medicine and Elizabeth Grice of the Perelman School of Medicine demonstrate how bacteria found in leishmaniasis skin lesions and an associated immune response drive disease burden and treatment failure—and suggest new possibilities for treatment of the parasitic disease.
LDI fellows are working with local communities to increase PrEP use through improving the message about the drug, reducing stigma, and normalizing the conversation about HIV infection.
According to Louise Moncla of the School of Veterinary Medicine, reinfections suggest that the H5N1 bird flu virus could circulate on farms indefinitely, creating opportunities for it to evolve into a more dangerous form.
FULL STORY →
Aaron Richterman of the Perelman School of Medicine says that there are large and underappreciated benefits of cash-transfer programs, such as potentially ending a tuberculosis epidemic.
FULL STORY →
Drew Weissman and Scott Hensley of the Perelman School of Medicine are testing a vaccine to prevent a strain of H5N1 bird flu in chickens and cattle.
FULL STORY →
Drew Weissman of the Perelman School of Medicine is launching a new RNA research hub that will use artificial intelligence to help train scientists and guide their experiments.
FULL STORY →
Paul Offit of the Perelman School of Medicine says that shingles is one of the worst pains in medicine, comparable to childbirth and corneal abrasions.
FULL STORY →
Scott Hensley of the Perelman School of Medicine says that there are fears of bird flu spreading at low levels through humans in a Missouri community.
FULL STORY →